ArticleMedComm2023

A novel Bruton's tyrosine kinase inhibitor JDB175 shows potent efficacy to suppress central nervous system lymphoma.

Yong Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.